GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 133 filers reported holding GENOMIC HEALTH INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $905,000 | -18.0% | 27,798 | -20.6% | 0.36% | -0.8% |
| Q1 2017 | $1,103,000 | -30.6% | 35,026 | -35.2% | 0.36% | -15.8% |
| Q4 2016 | $1,589,000 | -15.6% | 54,058 | -16.9% | 0.42% | -5.8% |
| Q3 2016 | $1,882,000 | +17.6% | 65,086 | +5.4% | 0.45% | +53.4% |
| Q2 2016 | $1,600,000 | -24.1% | 61,773 | -27.4% | 0.29% | -3.3% |
| Q1 2016 | $2,108,000 | -3.7% | 85,095 | +36.8% | 0.30% | +28.8% |
| Q4 2015 | $2,190,000 | -43.7% | 62,222 | -66.1% | 0.24% | -37.1% |
| Q3 2015 | $3,888,000 | +36.5% | 183,744 | +79.3% | 0.38% | +34.9% |
| Q2 2015 | $2,848,000 | +349.9% | 102,481 | +394.4% | 0.28% | +348.4% |
| Q1 2015 | $633,000 | +6.4% | 20,730 | +11.5% | 0.06% | +8.8% |
| Q4 2014 | $595,000 | +0.5% | 18,598 | -11.0% | 0.06% | +11.8% |
| Q3 2014 | $592,000 | +71.6% | 20,905 | +66.1% | 0.05% | +88.9% |
| Q2 2014 | $345,000 | – | 12,586 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |